Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Dof Inc. currently has 1 pending office action in its patent portfolio. This matter is being handled by 1 distinct examiner, indicating a concentrated point of contact for the company's current prosecution efforts. The portfolio is currently associated with 0 distinct art units in the available records.
The busiest examiner for the company is MI, QIUWEN, who is responsible for 1 busiest examiner pending office action. This single examiner accounts for all of the company's current pending workload. Practitioners should note that prosecution is centralized under this individual, which may lead to a consistent examination experience for the pending application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MI, QIUWEN | 1 | 68.4% | +49.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18854673 | ACELLULAR DERMAL TISSUE PREPARED USING SUPERCRITICAL FLUID EXTRACTION, AND USE THEREOF | MI, QIUWEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18854673 | ACELLULAR DERMAL TISSUE PREPARED USING SUPERCRITICAL FLUID EXTRACTION, AND USE THEREOF | MI, QIUWEN | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18854673 | ACELLULAR DERMAL TISSUE PREPARED USING SUPERCRITICAL FLUID EXTRACTION, AND USE THEREOF | MI, QIUWEN | — | §103§112 | Non-Final OA | — | Pending | Oct 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial